Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism
- Jazwa, A.
- Rojo, A.I.
- Innamorato, N.G.
- Hesse, M.
- Fernández-Ruiz, J.
- Cuadrado, A.
ISSN: 1557-7716, 1523-0864
Year of publication: 2011
Volume: 14
Issue: 12
Pages: 2347-2360
Type: Article